理性地设计的循环德克斯特林:用于神经药物向和BBB调制的神经药物向的智能班车
Mokhtar Rejili1, Gaurav Gupta2, Sachin Kumar Singh3
1Department of Biology, College of Sciences, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.
Bioorganic chemistry
|December 9, 2025
概括
在神经退行性疾病中,循环德克斯特林 (CD) 增强了通过血脑屏障 (BBB) 的药物输送. 这些循环寡糖通过调节细胞膜和线粒体功能来改善药物溶解性和神经保护.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 血脑屏障 (BBB) 限制了药物在治疗神经退行性疾病中的有效性,因为它具有选择性的透性.
- 传统药物通常面临着溶解性和访问神经点的挑战.
- 神经退行性疾病需要创新的治疗策略来克服生物障碍.
研究的目的:
- 审查基于循环二烯 (CD) 的药物输送系统的机制,以克服 BBB 的局限性.
- 探索CD如何增强药物溶解性,生物分布和神经保护.
- 讨论CD在治疗神经退行性病理方面的潜力.
主要方法:
- 对基于CD的药物输送系统的当代文献的审查.
- 对CD超分子结构和包容复合体形成的分析.
- 检查CD与细胞膜,脂质和载体的相互作用.
主要成果:
- CDs形成包容复合体,增强脂性药物的溶解性和药理动力学.
- 通过调节膜脂质,自和线粒体功能,CD显示神经保护作用.
- 磁盘显示了穿越BBB和调节关键病理过程的潜力,如神经炎症和蛋白质聚合.
结论:
- 通过改善药物输送和提供固有的神经保护,CDs为神经退行性疾病提供了一个有前途的治疗范式.
- 了解CD-药物结合机制,膜相互作用和传送效应对于优化它们的使用至关重要.
- 磁盘代表了开发新型神经治疗药物的多功能平台.
相关概念视频
The Blood-brain Barrier
52.2K
Overview
52.2K
Factors Affecting Drug Distribution: Physiological Barriers
659
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
659
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
184
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
184
Biopharmaceutical Factors Influencing Drug Product Design: Overview
222
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
222
Cellular Membranes and Drug Transport
1.4K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.4K


